PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in GLOBEFLEX CAPITAL L P  ·  23 quarters on record

This page tracks every 13F SEC filing in which GLOBEFLEX CAPITAL L P reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.76% (2021 Q1)
Avg. % of fund
0.28%
First filed
2020 Q2
Last filed
2025 Q4
Quarters held
23
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 452,606 — 0% 0.41% $2.7M $5.95
2025 Q3 UNCHANGED 452,606 — 0% 0.37% $2.4M $5.31
2025 Q2 UNCHANGED 452,606 — 0% 0.13% $1.6M $3.43
2025 Q1 UNCHANGED 452,606 — 0% 0.12% $1.3M $2.96
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08% Baron Wealth Management LLC 0.06%
← Back to GLOBEFLEX CAPITAL L P Holdings